Endogenous ligands for nuclear receptors: digging deeper
- PMID: 20956526
- PMCID: PMC3003339
- DOI: 10.1074/jbc.R110.182451
Endogenous ligands for nuclear receptors: digging deeper
Abstract
Nuclear receptors (NRs) are hormone-sensing transcription factors that translate dietary or endocrine signals into changes in gene expression. Therefore, the adoption of orphan NRs through the identification of their endogenous ligands is a key element for our understanding of their biology. In this minireview, we give an update on recent progress in regard to endogenous ligands for a cluster of NRs with high sequence homology, namely peroxisome proliferator-activated receptors α and γ, Rev-erbα, and related receptors. This knowledge about the nature and physiology of these ligands may create new opportunities for therapeutic drug development.
Figures
Similar articles
-
The nuclear receptor Rev-erbalpha is a liver X receptor (LXR) _target gene driving a negative feedback loop on select LXR-induced pathways in human macrophages.Mol Endocrinol. 2008 Aug;22(8):1797-811. doi: 10.1210/me.2007-0439. Epub 2008 May 29. Mol Endocrinol. 2008. PMID: 18511497 Free PMC article.
-
Combinatorial control of gene expression by nuclear receptors and coregulators.Cell. 2002 Feb 22;108(4):465-74. doi: 10.1016/s0092-8674(02)00641-4. Cell. 2002. PMID: 11909518 Review.
-
The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma _target gene and promotes PPARgamma-induced adipocyte differentiation.J Biol Chem. 2003 Sep 26;278(39):37672-80. doi: 10.1074/jbc.M304664200. Epub 2003 Jun 23. J Biol Chem. 2003. PMID: 12821652
-
A regulatory role for RIP140 in nuclear receptor activation.Mol Endocrinol. 1998 Jun;12(6):864-81. doi: 10.1210/mend.12.6.0123. Mol Endocrinol. 1998. PMID: 9626662
-
Macrophage nuclear receptors: Emerging key players in infectious diseases.PLoS Pathog. 2019 Mar 21;15(3):e1007585. doi: 10.1371/journal.ppat.1007585. eCollection 2019 Mar. PLoS Pathog. 2019. PMID: 30897154 Free PMC article. Review.
Cited by
-
Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis.J Thyroid Res. 2011;2011:361304. doi: 10.4061/2011/361304. Epub 2011 Jun 8. J Thyroid Res. 2011. PMID: 21760978 Free PMC article.
-
The Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARG) in Adipogenesis: Applying Knowledge from the Fish Aquaculture Industry to Biomedical Research.Front Endocrinol (Lausanne). 2017 May 22;8:102. doi: 10.3389/fendo.2017.00102. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28588550 Free PMC article. Review.
-
Dual _targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative.Liver Int. 2020 Nov;40(11):2860-2876. doi: 10.1111/liv.14643. Liver Int. 2020. PMID: 32841505 Free PMC article.
-
Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells.Arch Toxicol. 2020 Sep;94(9):3137-3155. doi: 10.1007/s00204-020-02808-0. Epub 2020 Jun 25. Arch Toxicol. 2020. PMID: 32588087 Free PMC article.
-
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.Nat Rev Cancer. 2012 Feb 9;12(3):181-95. doi: 10.1038/nrc3214. Nat Rev Cancer. 2012. PMID: 22318237 Free PMC article. Review.
References
-
- Aranda A., Pascual A. (2001) Physiol. Rev. 81, 1269–1304 - PubMed
-
- Perissi V., Rosenfeld M. G. (2005) Nat. Rev. Mol. Cell Biol. 6, 542–554 - PubMed
-
- Janowski B. A., Willy P. J., Devi T. R., Falck J. R., Mangelsdorf D. J. (1996) Nature 383, 728–731 - PubMed
-
- Delerive P., Furman C., Teissier E., Fruchart J., Duriez P., Staels B. (2000) FEBS Lett. 471, 34–38 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources